# US 2026/0167606 A1 · Crystalline 4-hydroxy-n,n-di-n-propyltryptammonium (4-ho-dpt) salts

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0167606 A1
- Document ID: US20260167606A1
- Status: Published application
- Kind: A1
- Application number: 19/386,665
- Filed: 2025-11-12
- Published: 2026-06-18
- Earliest claimed: 2020-05-20
- Assignees: Caamtech, Inc.
- Applicants: Caamtech, Inc.
- Inventors: Andrew R. CHADEAYNE
- Web page: https://patentgrep.com/patent/US20260167606A1

## CPC

- C07D 209/16: Tryptamines
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- C07C 57/15: Fumaric acid
- C07B 2200/13: Crystalline forms, e.g. polymorphs
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

This disclosure relates to crystalline bis(4-hydroxy-N,N-di-n-propyltryptammonium) fumarate tetrahydrate (4-HO-DPT fumarate·4H2O) and to crystalline 4-hydroxy-N,N-di-n-propyl-tryptammonium chloride (4-HO-DPT chloride). Compositions containing crystalline 4-HO-DPT fumarate·4H2O or crystalline 4-HO-DPT chloride, and methods of use are disclosed.

## Claims

### Claim 1

Crystalline bis(4-hydroxy-N,N-di-n-propyltryptammonium) fumarate tetrahydrate.

### Claim 2 (depends on 1)

Crystalline bis(4-hydroxy-N,N-di-n-propyltryptammonium) fumarate tetrahydrate according to claim 1, characterized by at least one of:
a monoclinic, P21/n space group at a temperature of about 200 K;
unit cell dimensions a=8.3495(8) Å, b=12.5138(11) Å, c=18.6631(17) Å, α=90°, β=100.902(3°), and γ=90°;
an x-ray powder diffraction pattern substantially similar to FIG. 4; and
an X-ray powder diffraction pattern characterized by at least two peaks selected from 8.5, 9.6, and 10.9° 2θ±0.2° 2θ.

### Claim 3 (depends on 1)

A composition comprising crystalline bis(4-hydroxy-N,N-di-n-propyltryptammonium) fumarate tetrahydrate according to claim 1 and an excipient.

### Claim 4 (depends on 1)

A composition comprising crystalline bis(4-hydroxy-N,N-di-n-propyltryptammonium) fumarate tetrahydrate according to claim 1 as a first component and a second component selected from at least one of (a) a serotonergic drug, (b) a purified psilocybin derivative, (c) a purified cannabinoid, (d) a purified terpene, (e) an adrenergic drug, (f) a dopaminergic drug, (g) a monoamine oxidase inhibitor, (h) a purified erinacine, or (i) a purified hericenone.

### Claim 5 (depends on 1)

A method of preventing or treating a psychological disorder comprising the step of:
administering to a subject in need thereof a therapeutically effective amount of crystalline bis(4-hydroxy-N,N-di-n-propyltryptammonium) fumarate tetrahydrate according to claim 1.

### Claim 6 (depends on 3)

A method of preventing or treating a psychological disorder comprising the step of:
administering to a subject in need thereof a composition according to claim 3.

### Claim 7 (depends on 4)

A method of preventing or treating a psychological disorder comprising the step of:
administering to a subject in need thereof a composition according to claim 4.

### Claim 8 (depends on 1)

A method of preventing or treating inflammation and/or pain comprising the step of:
administering to a subject in need thereof a therapeutically effective amount of crystalline bis(4-hydroxy-N,N-di-n-propyltryptammonium) fumarate tetrahydrate according to claim 1.

### Claim 9 (depends on 3)

A method of preventing or treating inflammation and/or pain comprising the step of:
administering to a subject in need thereof a composition according to claim 3.

### Claim 10 (depends on 4)

A method of preventing or treating inflammation and/or pain comprising the step of:
administering to a subject in need thereof a composition according to claim 4.
